Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Finasteride increases CD8+ T cells in BPH tissues.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

The CUBIC protocol allows detailed 3D visualization of proteins in mouse skin biopsies.

Cepharanthine could be a strong antiviral against COVID-19.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Genetic variants in specific genes cause central centrifugal cicatricial alopecia.

Puerariae Radix extract may be a promising cosmetic ingredient for skin health.

Alpha mangostin may protect certain breast cancer cells by activating the p53 pathway.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

uPA helps hair follicle cells grow.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

The combination treatment showed a higher response rate but no significant survival benefits.

FGF21 can help reduce skin inflammation caused by C. acnes.

Two new compounds were found to effectively reduce hair growth in mice.

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

HDAC inhibitors like Vorinostat and Entinostat may encourage hair regrowth and could be new treatments for hair loss conditions.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

A new genetic mutation in the CDH3 gene causes hair loss and eye problems in young people.